Reports Q3 revenue $3.9B, consensus $3.91B. “We continued to execute on our commitment to delivering sustainable and profitable growth this quarter. Our operating results and strong cash generation underscore the strength of our leadership position in consumer health, and reflect the strong foundation of the company we are building with durable advantage over the long-term,” said Thibaut Mongon, Chief Executive Officer and Director.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on KVUE:
- CVS Health (NYSE:CVS) Empties Certain Decongestants from Store Shelves
- CVS removing certain cold medicines containing phenylephrine, CNBC reports
- Kenvue price target lowered to $23 from $27 at HSBC
- Kenvue price target lowered to $27 from $30 at BofA
- RBC Analyst Bullish on Johnson & Johnson (NYSE: JNJ) Post-Spinoff